Evidence map›Paper›PMID 23743355›Full record

ReviewCancer letters2013

Tight junction proteins: from barrier to tumorigenesis.

E Aaron Runkle, David Mu

Abstract readReview
In one paragraph

Review in Cancer letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Biomolecules & biomedicine · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

E Aaron RunkleDepartment of Pathology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA. runkle@mail.med.upenn.edu
David Mu

Funding

Identification and characterization of driver gene(s) in recurrent lung cancer amR01CA127547 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MU, DAVID · 2008 to 2012
$1.5M
NCI NIH HHS CA127547NCI NIH HHS R01 CA127547
6 · The paper itself

Abstract

The tight junction is a multi-protein complex and is the apical most junctional complex in certain epithelial and endothelial cells. A great deal of attention has been devoted to the understanding of these proteins in contributing to the barrier function - that is, regulating the paracellular flux or permeability between adjacent cells. However, tight junction proteins are now recognized as having functions beyond the barrier. The focus of this review is to discuss the barrier function of the tight junction and to summarize the literature with a focus on the role of tight junction proteins in proliferation, transformation, and metastasis.

Indexed as

Cell Transformation, NeoplasticAnimalsClaudinsHumansNeoplasmsOccludinTight Junction ProteinsTight JunctionsZonula Occludens-1 ProteinClaudinsOccludinTight Junction ProteinsTJP1 protein, humanZonula Occludens-1 ProteinCancerClaudinMetastasisOccludinTight junction

Identifiers

PMID23743355
PMCPMC3752309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.